Molly C. Mulcahy

Molly C. Mulcahy

Auto-generated profile, based on publicly available information

Molly C. Mulcahy

University of Michigan School of Public Health, Department of Nutritional Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ESErin J. Stephenson
Erin J. Stephenson
ASAmanda S. Stayton
Amanda S. Stayton
ASAarti Sethuraman
Aarti Sethuraman
PRPrahlad K. Rao
Prahlad K. Rao
AMAlice Meyer
Alice Meyer
JHJoan C. Han
Joan C. Han
Almost all effective treatments for non-alcoholic fatty liver disease (NAFLD) involve reduction of adiposity, which suggests the metabolic axis between liver and adipose tissue is essential to NAFLD development. Since excessive dietary sugar intake may be an initiating factor for NAFLD, we have characterized the metabolic effects of liquid sucrose intake at concentrations relevant to typical human consumption in mice. We report that sucrose intake induces sexually dimorphic effects in liver, adipose tissue, and the microbiome; differences concordant with steatosis severity. We show that when steatosis is decoupled from impairments in insulin responsiveness, sex is a moderating factor that influences sucrose-driven lipid storage and the contribution of de novo fatty acid synthesis to the overall hepatic triglyceride pool. Our findings provide physiologic insight into how sex influences the regulation of adipose-liver crosstalk and highlight the importance of extrahepatic metabolism in the pathogenesis of diet-induced steatosis and NAFLD.

24 October 2024 in Endocrinology
Verified
Journal Article
Closed access
PDF file
MMMolly C Mulcahy
Molly C Mulcahy
NHNoura El Habbal
Noura El Habbal
JRJeAnna R Redd
JeAnna R Redd
HSHaijing Sun
Haijing Sun
BGBrigid Gregg
Brigid Gregg
Dave  BridgesDave Bridges
Dave Bridges
Growth differentiation factor-15 (GDF15) increases in circulation during pregnancy and has been implicated in food intake, weight loss, complications of pregnancy, and metabolic illness. We used a Gdf15 knockout mouse model (Gdf15-/-) to assess the role of GDF15 in body weight regulation and food intake during pregnancy. We found that Gdf15-/- dams consumed a similar amount of food and gained comparable weight during the course of pregnancy compared to Gdf15+/+ dams. Insulin sensitivity on gestational day 16.5 was also similar between genotypes. In the postnatal period, litter size, and survival rates were similar between genotypes. There was a modest reduction in birth weight of Gdf15-/- pups, but this difference was no longer evident postnatal day 3.5 to 14.5. We observed no detectable differences in milk volume production or milk fat percentage. These data suggest that GDF15 is dispensable for changes in food intake, and body weight as well as insulin sensitivity during pregnancy in a mouse model.

31 July 2019 in bioRxiv
Verified
Preprint
Open access
ESErin J. Stephenson
Erin J. Stephenson
JRJeAnna R. Redd
JeAnna R. Redd
DSDetrick Snyder
Detrick Snyder
QTQuynh T. Tran
Quynh T. Tran
BLBinbin Lu
Binbin Lu
DBDave Bridges
Dave Bridges
The mechanistic target of rapamycin (mTORC1) is a nutrient responsive protein kinase complex that helps co-ordinate anabolic processes across all tissues. There is evidence that signaling through mTORC1 in skeletal muscle may be a determinant of energy expenditure and aging and therefore components downstream of mTORC1 signaling may be potential targets for treating obesity and age-associated metabolic disease. Here, we generated mice with Ckmm-Cre driven ablation of Tsc1 , which confers constitutive activation of mTORC1 in skeletal muscle and performed unbiased transcriptional analyses to identify pathways and candidate genes that may explain how skeletal muscle mTORC1 activity regulates energy balance and aging. Activation of skeletal muscle mTORC1 produced a striking resistance to diet-and age-induced obesity without inducing systemic insulin resistance. We found that increases in energy expenditure following a high fat diet were mTORC1-dependent and that elevated energy expenditure caused by ablation of Tsc1 coincided with the upregulation of skeletal muscle-specific thermogenic mechanisms that involve sarcolipin-driven futile cycling of Ca 2+ through SERCA2. Additionally, we report that constitutive activation of mTORC1 in skeletal muscle reduces lifespan. These findings support the hypothesis that activation of mTORC1 and its downstream targets, specifically in skeletal muscle, may play a role in nutrient-dependent thermogenesis and aging.

3 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMolly C. Mulcahy
Molly C. Mulcahy
NHNoura El Habbal
Noura El Habbal
JRJeAnna R. Redd
JeAnna R. Redd
HSHaijing Sun
Haijing Sun
BGBrigid Gregg
Brigid Gregg
Dave  BridgesDave Bridges
Dave Bridges
Growth differentiation factor-15 (GDF15) increases in circulation during pregnancy and has been implicated in food intake, weight loss, complications of pregnancy, and metabolic illness. We used a Gdf15 knockout mouse model ( Gdf15 -/- ) to assess the role of GDF15 in body weight regulation and food intake during pregnancy. We found that Gdf15 -/- dams consumed a similar amount of food and gained comparable weight during the course of pregnancy compared to Gdf15 +/+ dams. Insulin sensitivity on gestational day 16.5 was also similar between genotypes. In the postnatal period, litter size, and survival rates were similar between genotypes. There was a modest reduction in birth weight of Gdf15 -/- pups, but this difference was no longer evident postnatal day 3.5 to 14.5. We observed no detectable differences in milk volume production or milk fat percentage. These data suggest that GDF15 is dispensable for changes in food intake, and body weight as well as insulin sensitivity during pregnancy in a mouse model.

24 November 2021 in Public Health Nutrition
Verified
Journal Article
Open access
PDF file
MMMolly C. Mulcahy
Molly C. Mulcahy
MTMartha Maria Tellez-Rojo
Martha Maria Tellez-Rojo
Alejandra CantoralAlejandra Cantoral
Alejandra Cantoral
MSMaritsa Solano-González
Maritsa Solano-González
ABAna Baylin
Ana Baylin
WPWei Perng
Wei Perng
Objective: To examine the associations of trimester-specific maternal prenatal carbohydrate (CHO) intake with offspring adiposity and metabolic health during peripuberty.Design: Prospective cohort study in which maternal dietary intake was collected via validated FFQ during each trimester. Offspring adiposity and metabolic biomarkers were evaluated at age 8–14 years. We used multivariable linear regression to examine associations between total energy-adjusted maternal CHO intake and offspring BMI z-score, skinfold thickness and metabolic syndrome risk z-score calculated as the average of waist circumference, fasting glucose, fasting C-peptide, TAG:HDL and systolic blood pressure + diastolic blood pressure/2.Setting: Mexico City, MexicoParticipants: 237 mother–child pairs in the Early Life Exposure in Mexico to Environmental Toxicants cohort.Results: We found non-linear associations of maternal CHO intake during pregnancy with offspring metabolic health during peripuberty. After adjusting for maternal age, and child age, sex and pubertal status, children whose mothers were in the fourth v. first quartile of total CHO intake during the third trimester had 0·42 (95 % CI –0·01, 0·08) ng/ml lower C-peptide and 0·10 (95 % CI –0·02, 0·22) units lower C-peptide insulin resistance (CP-IR). We found similar magnitude and direction of association with respect to net CHO intake during the first trimester and offspring C-peptide and CP-IR. Maternal CHO intake during pregnancy was not associated with offspring adiposity.Conclusions: In this study of mother–child pairs in Mexico City, children born to women in the highest quartile of CHO intake during pregnancy had lowest C-peptide and CP-IR during peripuberty. Additional research is warranted to replicate and identify mechanisms.

7 March 2022
Verified
Preprint
Open access
Dave  BridgesDave Bridges
Dave Bridges
MMMolly C Mulcahy
Molly C Mulcahy
JRJeAnna R. Redd
JeAnna R. Redd
Insulin tolerance tests are a standard and common method for evaluating the insulin sensitivity of an animal. In this assay, animals are fasted to normalize blood glucose and then challenged by an intraperitoneal injection of insulin. As glucose is transported into tissues and glucose production is suppressed, glucose levels drop. A more insulin sensitive animal will have a larger decrease in blood glucose. This has advantages over a glucose tolerance test which measures both insulin sensitivity and insulin responsiveness.